Global Quadrivalent Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Global Quadrivalent Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 103

Published Date: 17 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

This report studies the global Quadrivalent Flu Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Quadrivalent Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Quadrivalent Flu Vaccine that contribute to its increasing demand across many markets.

The global Quadrivalent Flu Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Quadrivalent Flu Vaccine total production and demand, 2018-2029, (K Doses)
Global Quadrivalent Flu Vaccine total production value, 2018-2029, (USD Million)
Global Quadrivalent Flu Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Quadrivalent Flu Vaccine consumption by region & country, CAGR, 2018-2029 & (K Doses)
U.S. VS China: Quadrivalent Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global Quadrivalent Flu Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Doses)
Global Quadrivalent Flu Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Quadrivalent Flu Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
This reports profiles key players in the global Quadrivalent Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, AstraZeneca, CSL, Abbott and GlaxoSmithKline, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Quadrivalent Flu Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Quadrivalent Flu Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Quadrivalent Flu Vaccine Market, Segmentation by Type
Intramuscular Injection
Nasal Spray
Intradermal Shot

Global Quadrivalent Flu Vaccine Market, Segmentation by Application
Hospital
Clinic
Public Health Agency
Other

Companies Profiled:
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline

Key Questions Answered
1. How big is the global Quadrivalent Flu Vaccine market?
2. What is the demand of the global Quadrivalent Flu Vaccine market?
3. What is the year over year growth of the global Quadrivalent Flu Vaccine market?
4. What is the production and production value of the global Quadrivalent Flu Vaccine market?
5. Who are the key producers in the global Quadrivalent Flu Vaccine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Quadrivalent Flu Vaccine Introduction
1.2 World Quadrivalent Flu Vaccine Supply & Forecast
1.2.1 World Quadrivalent Flu Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Quadrivalent Flu Vaccine Production (2018-2029)
1.2.3 World Quadrivalent Flu Vaccine Pricing Trends (2018-2029)
1.3 World Quadrivalent Flu Vaccine Production by Region (Based on Production Site)
1.3.1 World Quadrivalent Flu Vaccine Production Value by Region (2018-2029)
1.3.2 World Quadrivalent Flu Vaccine Production by Region (2018-2029)
1.3.3 World Quadrivalent Flu Vaccine Average Price by Region (2018-2029)
1.3.4 North America Quadrivalent Flu Vaccine Production (2018-2029)
1.3.5 Europe Quadrivalent Flu Vaccine Production (2018-2029)
1.3.6 China Quadrivalent Flu Vaccine Production (2018-2029)
1.3.7 Japan Quadrivalent Flu Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Quadrivalent Flu Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Quadrivalent Flu Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Quadrivalent Flu Vaccine Demand (2018-2029)
2.2 World Quadrivalent Flu Vaccine Consumption by Region
2.2.1 World Quadrivalent Flu Vaccine Consumption by Region (2018-2023)
2.2.2 World Quadrivalent Flu Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Quadrivalent Flu Vaccine Consumption (2018-2029)
2.4 China Quadrivalent Flu Vaccine Consumption (2018-2029)
2.5 Europe Quadrivalent Flu Vaccine Consumption (2018-2029)
2.6 Japan Quadrivalent Flu Vaccine Consumption (2018-2029)
2.7 South Korea Quadrivalent Flu Vaccine Consumption (2018-2029)
2.8 ASEAN Quadrivalent Flu Vaccine Consumption (2018-2029)
2.9 India Quadrivalent Flu Vaccine Consumption (2018-2029)

3 World Quadrivalent Flu Vaccine Manufacturers Competitive Analysis
3.1 World Quadrivalent Flu Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Quadrivalent Flu Vaccine Production by Manufacturer (2018-2023)
3.3 World Quadrivalent Flu Vaccine Average Price by Manufacturer (2018-2023)
3.4 Quadrivalent Flu Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Quadrivalent Flu Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Quadrivalent Flu Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Quadrivalent Flu Vaccine in 2022
3.6 Quadrivalent Flu Vaccine Market: Overall Company Footprint Analysis
3.6.1 Quadrivalent Flu Vaccine Market: Region Footprint
3.6.2 Quadrivalent Flu Vaccine Market: Company Product Type Footprint
3.6.3 Quadrivalent Flu Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Quadrivalent Flu Vaccine Production Value Comparison
4.1.1 United States VS China: Quadrivalent Flu Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Quadrivalent Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Quadrivalent Flu Vaccine Production Comparison
4.2.1 United States VS China: Quadrivalent Flu Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Quadrivalent Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Quadrivalent Flu Vaccine Consumption Comparison
4.3.1 United States VS China: Quadrivalent Flu Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Quadrivalent Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Quadrivalent Flu Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Quadrivalent Flu Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023)
4.5 China Based Quadrivalent Flu Vaccine Manufacturers and Market Share
4.5.1 China Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Quadrivalent Flu Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023)
4.6 Rest of World Based Quadrivalent Flu Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023)

5 Market Analysis by Type
5.1 World Quadrivalent Flu Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intramuscular Injection
5.2.2 Nasal Spray
5.2.3 Intradermal Shot
5.3 Market Segment by Type
5.3.1 World Quadrivalent Flu Vaccine Production by Type (2018-2029)
5.3.2 World Quadrivalent Flu Vaccine Production Value by Type (2018-2029)
5.3.3 World Quadrivalent Flu Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Quadrivalent Flu Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Public Health Agency
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Quadrivalent Flu Vaccine Production by Application (2018-2029)
6.3.2 World Quadrivalent Flu Vaccine Production Value by Application (2018-2029)
6.3.3 World Quadrivalent Flu Vaccine Average Price by Application (2018-2029)

7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Details
7.1.2 Sanofi Pasteur Major Business
7.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
7.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Pasteur Recent Developments/Updates
7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Quadrivalent Flu Vaccine Product and Services
7.2.4 AstraZeneca Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 CSL
7.3.1 CSL Details
7.3.2 CSL Major Business
7.3.3 CSL Quadrivalent Flu Vaccine Product and Services
7.3.4 CSL Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CSL Recent Developments/Updates
7.3.6 CSL Competitive Strengths & Weaknesses
7.4 Abbott
7.4.1 Abbott Details
7.4.2 Abbott Major Business
7.4.3 Abbott Quadrivalent Flu Vaccine Product and Services
7.4.4 Abbott Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Abbott Recent Developments/Updates
7.4.6 Abbott Competitive Strengths & Weaknesses
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Details
7.5.2 GlaxoSmithKline Major Business
7.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
7.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GlaxoSmithKline Recent Developments/Updates
7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Quadrivalent Flu Vaccine Industry Chain
8.2 Quadrivalent Flu Vaccine Upstream Analysis
8.2.1 Quadrivalent Flu Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Quadrivalent Flu Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Quadrivalent Flu Vaccine Production Mode
8.6 Quadrivalent Flu Vaccine Procurement Model
8.7 Quadrivalent Flu Vaccine Industry Sales Model and Sales Channels
8.7.1 Quadrivalent Flu Vaccine Sales Model
8.7.2 Quadrivalent Flu Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Quadrivalent Flu Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Quadrivalent Flu Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Quadrivalent Flu Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Quadrivalent Flu Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Quadrivalent Flu Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Quadrivalent Flu Vaccine Production by Region (2018-2023) & (K Doses)
Table 7. World Quadrivalent Flu Vaccine Production by Region (2024-2029) & (K Doses)
Table 8. World Quadrivalent Flu Vaccine Production Market Share by Region (2018-2023)
Table 9. World Quadrivalent Flu Vaccine Production Market Share by Region (2024-2029)
Table 10. World Quadrivalent Flu Vaccine Average Price by Region (2018-2023) & (USD/Dose)
Table 11. World Quadrivalent Flu Vaccine Average Price by Region (2024-2029) & (USD/Dose)
Table 12. Quadrivalent Flu Vaccine Major Market Trends
Table 13. World Quadrivalent Flu Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Doses)
Table 14. World Quadrivalent Flu Vaccine Consumption by Region (2018-2023) & (K Doses)
Table 15. World Quadrivalent Flu Vaccine Consumption Forecast by Region (2024-2029) & (K Doses)
Table 16. World Quadrivalent Flu Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Quadrivalent Flu Vaccine Producers in 2022
Table 18. World Quadrivalent Flu Vaccine Production by Manufacturer (2018-2023) & (K Doses)
Table 19. Production Market Share of Key Quadrivalent Flu Vaccine Producers in 2022
Table 20. World Quadrivalent Flu Vaccine Average Price by Manufacturer (2018-2023) & (USD/Dose)
Table 21. Global Quadrivalent Flu Vaccine Company Evaluation Quadrant
Table 22. World Quadrivalent Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Quadrivalent Flu Vaccine Production Site of Key Manufacturer
Table 24. Quadrivalent Flu Vaccine Market: Company Product Type Footprint
Table 25. Quadrivalent Flu Vaccine Market: Company Product Application Footprint
Table 26. Quadrivalent Flu Vaccine Competitive Factors
Table 27. Quadrivalent Flu Vaccine New Entrant and Capacity Expansion Plans
Table 28. Quadrivalent Flu Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Quadrivalent Flu Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Quadrivalent Flu Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 31. United States VS China Quadrivalent Flu Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 32. United States Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Quadrivalent Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Quadrivalent Flu Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023) & (K Doses)
Table 36. United States Based Manufacturers Quadrivalent Flu Vaccine Production Market Share (2018-2023)
Table 37. China Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Quadrivalent Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Quadrivalent Flu Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023) & (K Doses)
Table 41. China Based Manufacturers Quadrivalent Flu Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023) & (K Doses)
Table 46. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Market Share (2018-2023)
Table 47. World Quadrivalent Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Quadrivalent Flu Vaccine Production by Type (2018-2023) & (K Doses)
Table 49. World Quadrivalent Flu Vaccine Production by Type (2024-2029) & (K Doses)
Table 50. World Quadrivalent Flu Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Quadrivalent Flu Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Quadrivalent Flu Vaccine Average Price by Type (2018-2023) & (USD/Dose)
Table 53. World Quadrivalent Flu Vaccine Average Price by Type (2024-2029) & (USD/Dose)
Table 54. World Quadrivalent Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Quadrivalent Flu Vaccine Production by Application (2018-2023) & (K Doses)
Table 56. World Quadrivalent Flu Vaccine Production by Application (2024-2029) & (K Doses)
Table 57. World Quadrivalent Flu Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Quadrivalent Flu Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Quadrivalent Flu Vaccine Average Price by Application (2018-2023) & (USD/Dose)
Table 60. World Quadrivalent Flu Vaccine Average Price by Application (2024-2029) & (USD/Dose)
Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur Major Business
Table 63. Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
Table 64. Sanofi Pasteur Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Pasteur Recent Developments/Updates
Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Quadrivalent Flu Vaccine Product and Services
Table 70. AstraZeneca Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. CSL Basic Information, Manufacturing Base and Competitors
Table 74. CSL Major Business
Table 75. CSL Quadrivalent Flu Vaccine Product and Services
Table 76. CSL Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CSL Recent Developments/Updates
Table 78. CSL Competitive Strengths & Weaknesses
Table 79. Abbott Basic Information, Manufacturing Base and Competitors
Table 80. Abbott Major Business
Table 81. Abbott Quadrivalent Flu Vaccine Product and Services
Table 82. Abbott Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Abbott Recent Developments/Updates
Table 84. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 85. GlaxoSmithKline Major Business
Table 86. GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
Table 87. GlaxoSmithKline Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 88. Global Key Players of Quadrivalent Flu Vaccine Upstream (Raw Materials)
Table 89. Quadrivalent Flu Vaccine Typical Customers
Table 90. Quadrivalent Flu Vaccine Typical Distributors
List of Figure
Figure 1. Quadrivalent Flu Vaccine Picture
Figure 2. World Quadrivalent Flu Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Quadrivalent Flu Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 5. World Quadrivalent Flu Vaccine Average Price (2018-2029) & (USD/Dose)
Figure 6. World Quadrivalent Flu Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Quadrivalent Flu Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 9. Europe Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 10. China Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 11. Japan Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 12. Quadrivalent Flu Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 15. World Quadrivalent Flu Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 17. China Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 18. Europe Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 19. Japan Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 20. South Korea Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 21. ASEAN Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 22. India Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 23. Producer Shipments of Quadrivalent Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Quadrivalent Flu Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Quadrivalent Flu Vaccine Markets in 2022
Figure 26. United States VS China: Quadrivalent Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Quadrivalent Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Quadrivalent Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Quadrivalent Flu Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Quadrivalent Flu Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Market Share 2022
Figure 32. World Quadrivalent Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Quadrivalent Flu Vaccine Production Value Market Share by Type in 2022
Figure 34. Intramuscular Injection
Figure 35. Nasal Spray
Figure 36. Intradermal Shot
Figure 37. World Quadrivalent Flu Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Quadrivalent Flu Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Quadrivalent Flu Vaccine Average Price by Type (2018-2029) & (USD/Dose)
Figure 40. World Quadrivalent Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Quadrivalent Flu Vaccine Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Public Health Agency
Figure 45. Other
Figure 46. World Quadrivalent Flu Vaccine Production Market Share by Application (2018-2029)
Figure 47. World Quadrivalent Flu Vaccine Production Value Market Share by Application (2018-2029)
Figure 48. World Quadrivalent Flu Vaccine Average Price by Application (2018-2029) & (USD/Dose)
Figure 49. Quadrivalent Flu Vaccine Industry Chain
Figure 50. Quadrivalent Flu Vaccine Procurement Model
Figure 51. Quadrivalent Flu Vaccine Sales Model
Figure 52. Quadrivalent Flu Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Quadrivalent Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Global Quadrivalent Flu Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 103

Published Date: 17 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

This report studies the global Quadrivalent Flu Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Quadrivalent Flu Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Quadrivalent Flu Vaccine that contribute to its increasing demand across many markets.

The global Quadrivalent Flu Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study
Global Quadrivalent Flu Vaccine total production and demand, 2018-2029, (K Doses)
Global Quadrivalent Flu Vaccine total production value, 2018-2029, (USD Million)
Global Quadrivalent Flu Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Quadrivalent Flu Vaccine consumption by region & country, CAGR, 2018-2029 & (K Doses)
U.S. VS China: Quadrivalent Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global Quadrivalent Flu Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Doses)
Global Quadrivalent Flu Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
Global Quadrivalent Flu Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Doses)
This reports profiles key players in the global Quadrivalent Flu Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, AstraZeneca, CSL, Abbott and GlaxoSmithKline, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Quadrivalent Flu Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Quadrivalent Flu Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Quadrivalent Flu Vaccine Market, Segmentation by Type
Intramuscular Injection
Nasal Spray
Intradermal Shot

Global Quadrivalent Flu Vaccine Market, Segmentation by Application
Hospital
Clinic
Public Health Agency
Other

Companies Profiled:
Sanofi Pasteur
AstraZeneca
CSL
Abbott
GlaxoSmithKline

Key Questions Answered
1. How big is the global Quadrivalent Flu Vaccine market?
2. What is the demand of the global Quadrivalent Flu Vaccine market?
3. What is the year over year growth of the global Quadrivalent Flu Vaccine market?
4. What is the production and production value of the global Quadrivalent Flu Vaccine market?
5. Who are the key producers in the global Quadrivalent Flu Vaccine market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Quadrivalent Flu Vaccine Introduction
1.2 World Quadrivalent Flu Vaccine Supply & Forecast
1.2.1 World Quadrivalent Flu Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Quadrivalent Flu Vaccine Production (2018-2029)
1.2.3 World Quadrivalent Flu Vaccine Pricing Trends (2018-2029)
1.3 World Quadrivalent Flu Vaccine Production by Region (Based on Production Site)
1.3.1 World Quadrivalent Flu Vaccine Production Value by Region (2018-2029)
1.3.2 World Quadrivalent Flu Vaccine Production by Region (2018-2029)
1.3.3 World Quadrivalent Flu Vaccine Average Price by Region (2018-2029)
1.3.4 North America Quadrivalent Flu Vaccine Production (2018-2029)
1.3.5 Europe Quadrivalent Flu Vaccine Production (2018-2029)
1.3.6 China Quadrivalent Flu Vaccine Production (2018-2029)
1.3.7 Japan Quadrivalent Flu Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Quadrivalent Flu Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Quadrivalent Flu Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Quadrivalent Flu Vaccine Demand (2018-2029)
2.2 World Quadrivalent Flu Vaccine Consumption by Region
2.2.1 World Quadrivalent Flu Vaccine Consumption by Region (2018-2023)
2.2.2 World Quadrivalent Flu Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Quadrivalent Flu Vaccine Consumption (2018-2029)
2.4 China Quadrivalent Flu Vaccine Consumption (2018-2029)
2.5 Europe Quadrivalent Flu Vaccine Consumption (2018-2029)
2.6 Japan Quadrivalent Flu Vaccine Consumption (2018-2029)
2.7 South Korea Quadrivalent Flu Vaccine Consumption (2018-2029)
2.8 ASEAN Quadrivalent Flu Vaccine Consumption (2018-2029)
2.9 India Quadrivalent Flu Vaccine Consumption (2018-2029)

3 World Quadrivalent Flu Vaccine Manufacturers Competitive Analysis
3.1 World Quadrivalent Flu Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Quadrivalent Flu Vaccine Production by Manufacturer (2018-2023)
3.3 World Quadrivalent Flu Vaccine Average Price by Manufacturer (2018-2023)
3.4 Quadrivalent Flu Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Quadrivalent Flu Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Quadrivalent Flu Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Quadrivalent Flu Vaccine in 2022
3.6 Quadrivalent Flu Vaccine Market: Overall Company Footprint Analysis
3.6.1 Quadrivalent Flu Vaccine Market: Region Footprint
3.6.2 Quadrivalent Flu Vaccine Market: Company Product Type Footprint
3.6.3 Quadrivalent Flu Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Quadrivalent Flu Vaccine Production Value Comparison
4.1.1 United States VS China: Quadrivalent Flu Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Quadrivalent Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Quadrivalent Flu Vaccine Production Comparison
4.2.1 United States VS China: Quadrivalent Flu Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Quadrivalent Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Quadrivalent Flu Vaccine Consumption Comparison
4.3.1 United States VS China: Quadrivalent Flu Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Quadrivalent Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Quadrivalent Flu Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Quadrivalent Flu Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023)
4.5 China Based Quadrivalent Flu Vaccine Manufacturers and Market Share
4.5.1 China Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Quadrivalent Flu Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023)
4.6 Rest of World Based Quadrivalent Flu Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023)

5 Market Analysis by Type
5.1 World Quadrivalent Flu Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intramuscular Injection
5.2.2 Nasal Spray
5.2.3 Intradermal Shot
5.3 Market Segment by Type
5.3.1 World Quadrivalent Flu Vaccine Production by Type (2018-2029)
5.3.2 World Quadrivalent Flu Vaccine Production Value by Type (2018-2029)
5.3.3 World Quadrivalent Flu Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Quadrivalent Flu Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Public Health Agency
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Quadrivalent Flu Vaccine Production by Application (2018-2029)
6.3.2 World Quadrivalent Flu Vaccine Production Value by Application (2018-2029)
6.3.3 World Quadrivalent Flu Vaccine Average Price by Application (2018-2029)

7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Details
7.1.2 Sanofi Pasteur Major Business
7.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
7.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Pasteur Recent Developments/Updates
7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.2 AstraZeneca
7.2.1 AstraZeneca Details
7.2.2 AstraZeneca Major Business
7.2.3 AstraZeneca Quadrivalent Flu Vaccine Product and Services
7.2.4 AstraZeneca Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 AstraZeneca Recent Developments/Updates
7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 CSL
7.3.1 CSL Details
7.3.2 CSL Major Business
7.3.3 CSL Quadrivalent Flu Vaccine Product and Services
7.3.4 CSL Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CSL Recent Developments/Updates
7.3.6 CSL Competitive Strengths & Weaknesses
7.4 Abbott
7.4.1 Abbott Details
7.4.2 Abbott Major Business
7.4.3 Abbott Quadrivalent Flu Vaccine Product and Services
7.4.4 Abbott Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Abbott Recent Developments/Updates
7.4.6 Abbott Competitive Strengths & Weaknesses
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Details
7.5.2 GlaxoSmithKline Major Business
7.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
7.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GlaxoSmithKline Recent Developments/Updates
7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Quadrivalent Flu Vaccine Industry Chain
8.2 Quadrivalent Flu Vaccine Upstream Analysis
8.2.1 Quadrivalent Flu Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Quadrivalent Flu Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Quadrivalent Flu Vaccine Production Mode
8.6 Quadrivalent Flu Vaccine Procurement Model
8.7 Quadrivalent Flu Vaccine Industry Sales Model and Sales Channels
8.7.1 Quadrivalent Flu Vaccine Sales Model
8.7.2 Quadrivalent Flu Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Quadrivalent Flu Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Quadrivalent Flu Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Quadrivalent Flu Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Quadrivalent Flu Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Quadrivalent Flu Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Quadrivalent Flu Vaccine Production by Region (2018-2023) & (K Doses)
Table 7. World Quadrivalent Flu Vaccine Production by Region (2024-2029) & (K Doses)
Table 8. World Quadrivalent Flu Vaccine Production Market Share by Region (2018-2023)
Table 9. World Quadrivalent Flu Vaccine Production Market Share by Region (2024-2029)
Table 10. World Quadrivalent Flu Vaccine Average Price by Region (2018-2023) & (USD/Dose)
Table 11. World Quadrivalent Flu Vaccine Average Price by Region (2024-2029) & (USD/Dose)
Table 12. Quadrivalent Flu Vaccine Major Market Trends
Table 13. World Quadrivalent Flu Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Doses)
Table 14. World Quadrivalent Flu Vaccine Consumption by Region (2018-2023) & (K Doses)
Table 15. World Quadrivalent Flu Vaccine Consumption Forecast by Region (2024-2029) & (K Doses)
Table 16. World Quadrivalent Flu Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Quadrivalent Flu Vaccine Producers in 2022
Table 18. World Quadrivalent Flu Vaccine Production by Manufacturer (2018-2023) & (K Doses)
Table 19. Production Market Share of Key Quadrivalent Flu Vaccine Producers in 2022
Table 20. World Quadrivalent Flu Vaccine Average Price by Manufacturer (2018-2023) & (USD/Dose)
Table 21. Global Quadrivalent Flu Vaccine Company Evaluation Quadrant
Table 22. World Quadrivalent Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Quadrivalent Flu Vaccine Production Site of Key Manufacturer
Table 24. Quadrivalent Flu Vaccine Market: Company Product Type Footprint
Table 25. Quadrivalent Flu Vaccine Market: Company Product Application Footprint
Table 26. Quadrivalent Flu Vaccine Competitive Factors
Table 27. Quadrivalent Flu Vaccine New Entrant and Capacity Expansion Plans
Table 28. Quadrivalent Flu Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Quadrivalent Flu Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Quadrivalent Flu Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 31. United States VS China Quadrivalent Flu Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Doses)
Table 32. United States Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Quadrivalent Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Quadrivalent Flu Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023) & (K Doses)
Table 36. United States Based Manufacturers Quadrivalent Flu Vaccine Production Market Share (2018-2023)
Table 37. China Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Quadrivalent Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Quadrivalent Flu Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023) & (K Doses)
Table 41. China Based Manufacturers Quadrivalent Flu Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Quadrivalent Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production (2018-2023) & (K Doses)
Table 46. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Market Share (2018-2023)
Table 47. World Quadrivalent Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Quadrivalent Flu Vaccine Production by Type (2018-2023) & (K Doses)
Table 49. World Quadrivalent Flu Vaccine Production by Type (2024-2029) & (K Doses)
Table 50. World Quadrivalent Flu Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Quadrivalent Flu Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Quadrivalent Flu Vaccine Average Price by Type (2018-2023) & (USD/Dose)
Table 53. World Quadrivalent Flu Vaccine Average Price by Type (2024-2029) & (USD/Dose)
Table 54. World Quadrivalent Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Quadrivalent Flu Vaccine Production by Application (2018-2023) & (K Doses)
Table 56. World Quadrivalent Flu Vaccine Production by Application (2024-2029) & (K Doses)
Table 57. World Quadrivalent Flu Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Quadrivalent Flu Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Quadrivalent Flu Vaccine Average Price by Application (2018-2023) & (USD/Dose)
Table 60. World Quadrivalent Flu Vaccine Average Price by Application (2024-2029) & (USD/Dose)
Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur Major Business
Table 63. Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
Table 64. Sanofi Pasteur Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Pasteur Recent Developments/Updates
Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca Quadrivalent Flu Vaccine Product and Services
Table 70. AstraZeneca Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. CSL Basic Information, Manufacturing Base and Competitors
Table 74. CSL Major Business
Table 75. CSL Quadrivalent Flu Vaccine Product and Services
Table 76. CSL Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CSL Recent Developments/Updates
Table 78. CSL Competitive Strengths & Weaknesses
Table 79. Abbott Basic Information, Manufacturing Base and Competitors
Table 80. Abbott Major Business
Table 81. Abbott Quadrivalent Flu Vaccine Product and Services
Table 82. Abbott Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Abbott Recent Developments/Updates
Table 84. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 85. GlaxoSmithKline Major Business
Table 86. GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
Table 87. GlaxoSmithKline Quadrivalent Flu Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 88. Global Key Players of Quadrivalent Flu Vaccine Upstream (Raw Materials)
Table 89. Quadrivalent Flu Vaccine Typical Customers
Table 90. Quadrivalent Flu Vaccine Typical Distributors
List of Figure
Figure 1. Quadrivalent Flu Vaccine Picture
Figure 2. World Quadrivalent Flu Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Quadrivalent Flu Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 5. World Quadrivalent Flu Vaccine Average Price (2018-2029) & (USD/Dose)
Figure 6. World Quadrivalent Flu Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Quadrivalent Flu Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 9. Europe Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 10. China Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 11. Japan Quadrivalent Flu Vaccine Production (2018-2029) & (K Doses)
Figure 12. Quadrivalent Flu Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 15. World Quadrivalent Flu Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 17. China Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 18. Europe Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 19. Japan Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 20. South Korea Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 21. ASEAN Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 22. India Quadrivalent Flu Vaccine Consumption (2018-2029) & (K Doses)
Figure 23. Producer Shipments of Quadrivalent Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Quadrivalent Flu Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Quadrivalent Flu Vaccine Markets in 2022
Figure 26. United States VS China: Quadrivalent Flu Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Quadrivalent Flu Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Quadrivalent Flu Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Quadrivalent Flu Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Quadrivalent Flu Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Quadrivalent Flu Vaccine Production Market Share 2022
Figure 32. World Quadrivalent Flu Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Quadrivalent Flu Vaccine Production Value Market Share by Type in 2022
Figure 34. Intramuscular Injection
Figure 35. Nasal Spray
Figure 36. Intradermal Shot
Figure 37. World Quadrivalent Flu Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Quadrivalent Flu Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Quadrivalent Flu Vaccine Average Price by Type (2018-2029) & (USD/Dose)
Figure 40. World Quadrivalent Flu Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Quadrivalent Flu Vaccine Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Public Health Agency
Figure 45. Other
Figure 46. World Quadrivalent Flu Vaccine Production Market Share by Application (2018-2029)
Figure 47. World Quadrivalent Flu Vaccine Production Value Market Share by Application (2018-2029)
Figure 48. World Quadrivalent Flu Vaccine Average Price by Application (2018-2029) & (USD/Dose)
Figure 49. Quadrivalent Flu Vaccine Industry Chain
Figure 50. Quadrivalent Flu Vaccine Procurement Model
Figure 51. Quadrivalent Flu Vaccine Sales Model
Figure 52. Quadrivalent Flu Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now